Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
SARS-CoV-2 recruits a haem metabolite to evade antibody immunity
Annachiara Rosa, Valerie E Pye, Carl Graham, et al.
Nature Microbiology
|
October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Elife
|
January 24, 2023
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
Nathan J Cheetham, Milla Kibble, Andrew Wong, et al.
The Lancet. Oncology
|
April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
Nature Medicine
|
September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
November 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Medrxiv : the Preprint Server for Health Sciences
|
February 3, 2021
SARS-CoV-2 recruits a haem metabolite to evade antibody immunity
Annachiara Rosa, Valerie E Pye, Carl Graham, et al.
Nature Microbiology
|
October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Elife
|
January 24, 2023
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
Nathan J Cheetham, Milla Kibble, Andrew Wong, et al.
The Lancet. Oncology
|
April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
Nature Medicine
|
September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine
|
November 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Page
of 5